Abnormal intracortical facilitation in early-stage Huntington's disease

Clinical Neurophysiology

Volumn 118, Issue 5, 2007, Pages 1149-1154

  Nardone, R ^a   Lochner, P ^a   Marth, R ^a   Ausserer, H ^a   Bratti, A ^a   Tezzon, F ^a  

^a F Tappeiner Hospital   (Italy)

Author keywords

Early stage Huntington's disease; Glutamatergic transmission; Intracortical facilitation; Transcranial magnetic stimulation

Indexed keywords

GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; ELECTRONEUROLOGY; EVOKED CORTICAL RESPONSE; FACILITATION; FEMALE; HUMAN; HUNTINGTON CHOREA; INTRACORTICAL FACILITATION; MALE; MOTOR CORTEX; MOTOR PERFORMANCE; NERVE CELL DEGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION;

ACTION POTENTIALS; ADULT; DISEASE PROGRESSION; ELECTROMYOGRAPHY; FEMALE; GLUTAMIC ACID; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; MOTOR CORTEX; NEURAL CONDUCTION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 34047177037     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2007.01.009     Document Type: Article

References (46)

1. Abbruzzese G., Buccolieri A., Marchese R., Trompetto C., Mandich P., and Schieppati M. Intracortical inhibition and facilitation are abnormal in Huntington's disease: a paired magnetic stimulation study. Neurosci Lett 228 (1997) 87-90
2. Albin R.L., Young A.B., Penney J.B., Handelin B., Balfour R., Anderson K.D., et al. Abnormalities of striatal projection neurones and N-methyl-d-aspartate receptors in presymptomatic Huntington's disease. N Engl J Med 322 (1990) 1293-1298
3. Andrews T., Weeks R., Turjanski N., Gunn R., Watkins L., Sahakian B., et al. Huntington's disease progression PET and clinical observations. Brain 122 (1999) 2353-2363
4. Aylward E.H., Brandt J., Codori A.M., Clark C., Ammann W., and Martin W.R. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology 44 (1994) 823-828
5. Aylward E.H., Codori A.M., Barta P.E., Pearlson G.D., and Harris G.J. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Arch Neurol 53 (1996) 1293-1296
6. Aylward E.H., Codori A.M., Rosenblatt A., Sherr M., Brandt J., Stine O.C., et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord 15 (2000) 552-560
7. Benardo L.S. N-Methyl-d-aspartate transmission modulates GABAB-mediated inhibition of rat hippocampal pyramidal neurons in vitro. Neuroscience 68 (1995) 637-643
8. Bustos G., Abarca J., Forray M.I., Gysling K., Bradberry C.W., and Roth R.H. Regulation of excitatory amino acid release by N-methyl-d-aspartate receptors in rat striatum: in vivo microdialysis studies. Brain Res 585 (1992) 105-115
9. Cepeda C., Ariano C.R., Calvert M.A., Flores-Hernandez J., Chandler S.H., Leavitt B.R., et al. NMDA receptor function in mouse models of Huntington's disease. J Neurosci Res 15 (2001) 525-539
10. Connors B.W., Malenka R.C., and Silva L.R. Two inhibitory postsynaptic potentials, and GABAA and GABAB receptor-mediated responses in neocortex of rat and cat. J Physiol 406 (1988) 443-468
11. Coyle J.T., and Schwarcz R. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature 263 (1976) 244-246
12. De Boo G.M., Tibben A., Lanser J.B., Jennekens-Schinkel A., Hermans J., Maat-Kievit A., et al. Early cognitive and motor symptoms in identified carriers for Huntington disease. Arch Neurol 54 (1997) 1353-1357
13. Di Lazzaro V., Oliviero A., Meglio M., Cioni B., Tamburini G., and Tonali P. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin Neurophysiol 111 (2000) 794-799
14. Di Lazzaro V., Oliviero A., Profice P., Pennini M.A., Pilato F., Zito G., et al. Ketamine increases motor cortex excitability to transcranial magnetic stimulation. J Physiol 547 (2003) 485-496
15. Garvey M.A., Ziemann U., Becker D.A., Denckla M.B., Barker C.A., and Wassermann E.M. New graphical method to measure silent periods evoked by transcranial magnetic stimulation. Clin Neurophysiol 112 (2001) 1451-1460
16. Goldberg Y.P., Andrew S.E., Clarke L.A., and Hayden M.R. A PCR method for accurate assessment of trinucleotide repeat expansion in Huntington's disease. Hum Mol Gent 6 (1993) 635-636
17. Grafton S.T., Mazziotta J.C., Pahl J.J., St George-Hyslop P., Haines J.L., Gusella J., et al. A comparison of neurological, metabolic, structural, and genetic evaluations in person at risk for Huntington's disease. Ann Neurol 28 (1990) 614-6121
18. HA/WFN; International Huntington Association and the World Federation of neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. J Med Genet 1994;31:555-559.
19. Hallett M. Transcranial magnetic stimulation and the human brain. Nature 406 (2000) 147-150
20. Hanajima R., Ugawa Y., Terao Y., Furubayashi T., Machii K., Shiio Y., et al. Intracortical inhibition of the motor cortex is normal in chorea. J Neurol Neurosurg Psychiatry 66 (1999) 783-786
21. Hayden M.R., Hewitt J., Stoessl A.J., Clark C., Ammann W., and Martin W.R. The combinate use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease. Neurology 37 (1987) 1441-1447
22. Hwa G.G., and Avoli M. Excitatory postsynaptic potentials recorded from regular-spiking cells in layers II/III of rat sensorimotor cortex. J Neurophysiol 67 (1992) 728-737
23. Ilic T.V., Meintzschel F., Cleff U., Ruge D., Kessler K.R., and Ziemann U. Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity. J Physiol 545 (2002) 153-167
24. Kirkwood S.C., Siemers E., Bond C., Conneally P.M., Christian J.C., and Foroud T. Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene. Arch Neurol 57 (2000) 1040-1044
25. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., et al. Corticocortical inhibition in human motor cortex. J Physiol 471 (1993) 501-519
26. Jarabek B.R., Yasuda R.P., and Wolfe B.B. Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model. Brain 127 (2004) 505-516
27. Lorenzano C., Dinapoli L., Gilio F., Suppa A., Bagnato S., Currá A., et al. Motor cortex excitability studied with repetitive transcranial magnetic stimulation in patients with Huntington's disease. Clin Neurophysiol 117 (2006) 1677-1681
28. Mc Geer E.G., and Mc Geer P.L. Duplication of biochemical changes in Huntington's chorea by intrastriatal injections of glutamic and kainic acids. Nature 263 (1976) 517-519
29. Modugno N., Currà, Giovanelli M., Priori A., Squitieri F., Ruggieri S., et al. The prolonged cortical silent period in patients with Huntington's disease. Clin Neurophysiol 112 (2001) 1470-1474
30. Moghaddam B., Adams B., Verma A., and Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 7 (1997) 2921-2927
31. Priori A., Berardelli A., Inghilleri M., Polidori L., and Manfredi M. Electromyographic silent period after transcranial brain stimulation in Huntington's disease. Mov Disord 9 (1994) 178-182
32. Roick H., von Giesen H.J., Lange H.W., and Benecke R. Postexcitatory inhibition in Huntington's disease. Mov Disord 7 I (1992) 27
33. Rossini P., Barker A., Berardelli A., Caramia M.D., Caruso G., Cracco R.Q., et al. Non invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application: Report of IFCN committee. Electroenceph Clin Neurophysiol 91 (1994) 79-92
34. Rothwell J.C. Techniques of transcranial magnetic stimulation. In: Boniface S.J., and Ziemann U. (Eds). Plasticity in human nervous system. Investigations with transcanial magnetic stimulation (2003), Cambridge University Press, Cambridge 26-61
35. Sanger T.D., Garg R.R., and Chen R. Interaction between two different inhibitory systems in the human motor cortex. J Physiol 530 (2001) 307-317
36. Shoulson I., and Fahn S. Huntington's disease: clinical care and evaluation. Neurology 29 (1979) 1-3
37. Shoulson I., Odoroff C., Oakes D., Behr J., Goldblatt D., Caine E., et al. A controlled clinical trial of baclofen as protective therapy in early Huntington's disease. Ann Neurol 25 (1989) 252-259
38. Schwenkreis P., Liepert J., Witscher K., Fisher W., Weiller C., Malin J.P., et al. Riluzole suppresses motor cortex facilitation in correlation to its plasma level: a study using transcranial magnetic stimulation. Exp Brain Res 135 (2000) 293-299
39. Siemers E., Foroud T., Bill D.J., Sorbel J., Norton JA J., Hodes M.E., et al. Motor cortex changes in presymptomatic Huntington disease gene carriers. Arch Neurol 53 (1996) 487-492
40. Tegenthoff M., Vorgerd M., Juskowiak F., Roos V., and Malin J.P. Postexcitatory inhibition after transcranial magnetic single and double brain stimulation in Huntington's disease. Electroenceph Clin Neurophysiol 101 (1996) 298-303
41. The Huntington's disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.
42. Werhahn K.J., Kunesch E., Noachtar S., Benecke R., and Classen J. Differential effects on motocortical inhibition induced by blockade of GABA uptake in humans. J Physiol 517 (1999) 591-597
43. Young A.B., Greenamyre T., Hollingsworth Z., Albin R., D'Amato C., Shoulson I., et al. NMDA receptor losses in putamen from patients with Huntington's disease. Science 241 (1988) 981-983
44. Ziemann U., Lonnecker S., Steinhoff B.J., and Paulus. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Annals of Neurology 40 3 (1996) 367-378
45. Ziemann U., Chen R., Cohen L.G., and Hallett M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology 51 (1998) 1320-1324
46. Ziemann U. Assessment of motor cortex and descending motor pathways. In: Brown W.C., and Bolton C.F. (Eds). Neuromuscular function and disease. Basic clinical and electrodiagnostic aspects vol. 1 (2002), Saunders, Philadeplhia 189-221